Dopaminergic transmission has been suggested to be a main mechanism mediating reinforcement, withdrawal and craving associated with alcohol addiction. We measured here striatal dopamine (DA) transporter binding from 27 alcoholics within 4 days after cessation of prolonged heavy drinking and after a 4-week period of abstinence with single photon emission computed tomography (SPECT) using a cocaine analogue, iodine-123-␤-CIT. Controls were 29 healthy volunteers. Blind quantitative analyses of the SPECT data revealed markedly lower DA transporter binding in alcoholics on admission for detoxification than in the non-alcoholic controls. After a 4-week period of abstinence DA transporter binding increased significantly in the alcoholics (P Ͻ 0.0001) reaching the levels of the healthy controls. The most substantial recovery in DA transporter binding occurred during the first 4 days of abstinence. The data indicate that prolonged heavy drinking decreases DA transporter binding and distrubs synaptic dopamine transport. This may sensitize alcoholics to dopaminergic transmission, which may lead to early relapse after ethanol withdrawal.
The mesolimbic dopaminergic system is the most important pathway mediating reinforcement and addiction to drugs of abuse 1 and even behavioral dependence. 2 The mechanisms, by which voluntary ethanol intake progresses to compulsive dependence are, however, largely unclear. In experimental animals, decreased brain DA levels have been observed after abrupt cessation of alcohol administration. [3] [4] [5] Plasma homovanillic acid, the major metabolite of DA, has been found to be low in abstinent alcoholics. 6 The most important mechanism to eliminate synaptic DA are DA transporters. [7] [8] [9] Previous studies in abstinent alcoholics have indicated decreased dopamine D2 receptors and normal striatal DA transporter binding. 10 Striatal DA transporter binding has also been reported to be normal in violent early onset alcoholics. 11, 12 Such binding has, however, not been previously examined during alcohol abuse or shortly after withdrawal.
In order to explore the effect of excessive ethanol consumption on dopaminergic transmission, we measured here DA transporter binding with [
-carbometoxy-3␤-(4-iodophenyl)tropane) after alcohol withdrawal and after a 4-week period of abstinence.
Striatal DA transporter binding was lower in alcoholics on admission for detoxification than in healthy controls, 6.4 (95% confidence intervals, 6.2-6.6), vs 7.1 (95% CI, 6.8-7.4), respectively. Those alcoholics (n = 5) who had alcohol in their blood at the time of brain imaging showed the lowest levels with a mean value of 6.0 (95% CI, 5.5-6.5).
Striatal DA transporter binding increased significantly (P Ͻ 0.0001) during abstinence (Figures 1 and  2 ). The mean value of the 27 alcoholics after 4 weeks of supervised abstinence was 7.3 (95% CI, 7.1-7.5), which was similar to the levels of the healthy controls. The Image Section (pp 104-105) demonstrates a typical SPECT scan from an alcoholic patient at the time of withdrawal and after 4 weeks of abstinence. Stepwise linear regression showed that the number of days elapsed between the last drink and the first brain imaging was the most significant predictor of the change in DA transporter binding during abstinence (P Ͻ 0.01), the correlation being an inverse one. The amount of benzodiazepines given before the first imaging correlated positively with the change (P Ͻ 0.05), but age, sex, amount of alcohol consumed, duration of the last drinking bout and SSA (Selected Severity Scale) 13 score were not significant predictors.
There were five patients who were not treated with benzodiazepines. They showed a similar increase in DA transporter binding during the 4-week period of abstinence (from 6.4 to 7.3, P Ͻ 0.01) as the group of alcoholics who were treated with benzodiazepines. After omitting these five patients from the linear regression analysis, the amount of benzodiazepines no longer appeared to predict the increase in DA binding, although the duration of abstinence before imaging still did so, with an inverse relationship (P Ͻ 0.01).
Current data show that prolonged heavy drinking of ethanol leads to decreased striatal DA transporter binding in human brain during the first 2 days after alcohol withdrawal but returns to normal levels within a few days. To our knowledge, this is the first demonstration of an effect of alcohol drinking on DA transporters in humans. Previous observations 10, 12 indicating similar DA transporter values in alcoholics and in nonalcoholics as well as the findings by Tiihonen et al 11 on early onset violent alcoholics may evidently be explained by the fact that the measurements were performed up to several weeks after cessation of drinking. In experimental animals, chronic alcohol feeding has been found to lead to downregulation of DA transporter binding, which disappears after cessation of alcohol feeding. 14 Our observations indicate similar effects in humans.
The synaptic DA transporters provide the main mechanism to eliminate synaptic dopamine. [7] [8] [9] The mechanism of changes in DA transporter density are however, unknown. Reduction in dopaminergic impulse flow does not reduce DA transporter level. 15 Destruction and recovery of dopaminergic nerve terminals would explain alternations in dopaminergic activity and DA transporter levels. However, it is unclear whether alcohol drinking could cause this. The rapid reintegration of dopaminergic activity observed in this study may suggest another mechanism.
Interestingly, previous studies have indicated the occurrence of transient parkinsonism in alcoholics. 16 Since SPECT scanning is employed for the routine clinical diagnosis of early Parkinson's disease it is important to note that prolonged heavy drinking may cause false positive findings in individual patients. Our observations support the suggestion of Shandling et al 17 that transient parkinsonism in alcoholics during withdrawal may not reflect such nigral pathology, which would predict the future development of parkinsonism.
At this time we cannot rule out the possibility that a concomitant benzodiazepine treatment, which was given in relation to the severity of the withdrawal syndrome, at the time of detoxification may also affect DA transporter binding. Patients without any medication also showed a significant increase in striatal DA transporter binding during abstinence, suggesting that benzodiazepine treatment should not cause any significant bias.
Taken together, the present data show that striatal DA transporter binding decreases as a result of heavy alcohol consumption. It is, however, restored following cessation of drinking, which suggests a reversible effect. Disturbed dopaminergic transmission in withdrawal state [3] [4] [5] and inhibition of uptake with reduced DA transporter density may lead to sensitization to dopaminergic impulses, which may account for an increased risk for early relapse in alcohol-dependent individuals.
Methods

Participants
The subjects recruited were 27 alcoholics, 22 men and five women (age ranging from 24 to 69 years, mean 42.2, SD 10.3), who were admitted for detoxification after drinking alcohol, mean 3.5 ± 1.4 g kg −1 day −1 for men and 3.5 ± 1.2 g kg −1 day −1 for women, respectively. Controls were 29 healthy subjects, 12 men and 17 women, aged from 19 to 73 years (mean 37.7, SD 13.4), who volunteered for the study. They had fully abstained from alcohol for at least one week before brain imaging. All the subjects were Caucasians.
Subjects who had any central nervous system or head trauma in their history and those who were using neuroleptic or antidepressive drugs were excluded from both groups. Head MRI-examinations were performed to exclude any structural brain pathology. Liver function tests and laboratory markers of alcohol abuse (MCV, CDT, GGT) were used to monitor sobriety and all the parameters indicated true abstinence during the follow-up. Use of illegal drugs was excluded by urine screening. The patients were allowed to take only the benzodiazepines used for detoxification. The variables considered were age, sex, duration of the last drinking bout, amount of alcohol consumed daily during the last drinking bout, number of days of abstinence preceding the first imaging, withdrawal symptom score in SSA scale and the total amount of benzodiazepines given to the patient preceding the first imaging. All the subjects gave their written informed consent after having received detailed information of the study. The protocol was approved by the Ethical Committee of the Oulu University Hospital.
SPECT scanning SPECT studies were performed using a dual head gamma camera (ADAC Vertex) equipped with high resolution fan beam collimators. SPECT scans were done 24 h after the slow (30 s) intravenous injection of [ 123 I]␤-CIT. The ligand was synthesized as described previously in detail. 18 The physicist who performed regions-of-interest analyses was blind to the demographic data on the subjects. Transaxial slices oriented along the orbitomeatal line were reconstructed and the two slices corresponding to the highest striatal uptake were summed. The regions-of-interest were drawn over the right and left striatum (STR) using a color scale with about 60% isocontour cutoff boundaries for delineation. Frontal white matter (FWM) regions-of-interest were drawn on the slice about 60 mm superior to the orbitomeatal line. Striatal DA transporter binding was calculated as the ratio of the total binding in striatum minus the non-displaceable binding in FWM to the non-displaceable binding in FWM, ie (STR − FWM)/FWM. As it has been shown that a state of equilibrium exists in the striatal and occipital areas 24 h after the injection, the ratio at this time point can be used as an estimate of the binding potential. 19 SPECT scans were repeated for each alcoholic 4 weeks after the first scanning and the difference of the binding in each individual between the two measurements of striatal DA transporter binding was calculated.
Statistical methods
Continuous variables were compared using the repeated measures ANOVA-test. For correlation analyses, Spearman's rank correlation coefficients were calculated. Stepwise linear regression analysis (SSPS for windows) was performed to test which factors significantly influenced the change in DA transporter binding during the 4-week period of abstinence.
